ClinicalTrials.Veeva

Menu

Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group

C

Clinical Hospital Center, Split

Status

Unknown

Conditions

Ulcerative Colitis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Mucosal inflammation in patients with UC is the result of immunosuppression disturbance because decreasing number of regulatory T ly and activation IL 17

Enrollment

32 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • endoscopic confirmed diagnosis

Exclusion criteria

  • corticosteroid or immunosuppressive therapy

Trial design

32 participants in 2 patient groups

2
Description:
control group
patients with UC
Description:
patients with UC, without corticosteroid or immunosuppressive therapy

Trial contacts and locations

1

Loading...

Central trial contact

Jasna Ajdukovic, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems